Odyssey Health (ODYY) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026)
Odyssey Health (ODYY) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 8.20% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 88.89% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -30.89% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 47.37% |
| 10 | Odyssey Health | - | - | - | -1,327.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -1,327.04% |
| Oct 31, 2025 | 62.42% |
| Jul 31, 2025 | 91.67% |
| Apr 30, 2025 | 75.96% |
| Jan 31, 2025 | -101.75% |
| Oct 31, 2024 | 0.00% |
| Jul 31, 2024 | -1,100.00% |
| Apr 30, 2024 | 50.00% |
| Jan 31, 2024 | 700.00% |
| Oct 31, 2023 | 66.67% |
| Jul 31, 2023 | 50.00% |
| Apr 30, 2023 | 50.00% |
| Jan 31, 2023 | 0.00% |
| Oct 31, 2022 | -50.00% |
| Jul 31, 2022 | 33.33% |
| Apr 30, 2022 | 69.23% |